Related Experiment Video
Updated: Mar 9, 2026

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
Bromodomains in Protozoan Parasites: Evolution, Function, and Opportunities for Drug Development
Victoria Jeffers1, Chunlin Yang1, Sherri Huang1
1Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Bromodomain proteins are crucial for parasite survival and offer new drug targets. Inhibitors targeting these proteins show promise as novel antiparasitic agents against drug-resistant infections.
Area of Science:
- Parasitology
- Molecular Biology
- Drug Discovery
Background:
- Parasitic infections pose a significant global health challenge, exacerbated by increasing drug resistance.
- Lysine acetylation is vital for the survival of apicomplexan and kinetoplastid parasites.
- Bromodomain proteins, as "readers" of lysine acetylation, regulate gene expression and are potential therapeutic targets.
Purpose of the Study:
- To review the essential roles of bromodomain proteins in parasite biology.
- To highlight the efficacy of bromodomain inhibitors as antiparasitic agents.
- To perform a phylogenetic analysis of bromodomain proteins in pathogens for drug development.
Main Methods:
- Literature review of recent studies on bromodomain proteins in parasites.
- Analysis of existing research on bromodomain inhibitors' efficacy.
- Phylogenetic analysis of bromodomain proteins in key parasitic species.
Main Results:
- Bromodomain proteins are essential for parasite viability, invasion, and stage switching.
- Bromodomain inhibitors demonstrate significant antiparasitic activity.
- Phylogenetic analysis revealed unique parasite-specific bromodomain features.
Conclusions:
- Bromodomain proteins represent a promising class of drug targets for combating parasitic infections.
- Bromodomain inhibitors offer a novel therapeutic strategy against drug-resistant parasites.
- Understanding parasite-specific bromodomain features can guide future drug development efforts.
More Related Videos
Related Concept Videos
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Membrane Domains
Protein Domains
The membrane comprises a group of distinct proteins responsible for carrying out a cell's specific function. For example, the plasma membrane of the human sperm, or a single germ cell, contains a unique set of proteins in the...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Diversity of Protists II

